Abdominal tuberculosis represents a form of extrapulmonary tuberculosis that specifically affects the gastrointestinal system and associated abdominal organs. This manifestation typically arises from the ingestion of Mycobacterium tuberculosis bacilli or from the hematogenous spread of infection from other primary sites, such as the lungs. Unlike pulmonary tuberculosis, abdominal tuberculosis often presents with vague and non-specific symptoms, leading to frequent misdiagnosis and delayed treatment. Recognizing the clinical patterns and understanding the underlying pathophysiology is essential for timely intervention.
Pathogenesis and Transmission
The development of abdominal tuberculosis usually occurs through several distinct pathways. The most common route involves the ingestion of contaminated sputum, particularly in individuals with active pulmonary tuberculosis who swallow infectious droplets. Alternatively, the bacteria can spread via the bloodstream from a primary focus, seeding multiple abdominal organs. Once inside the gastrointestinal tract, the bacilli invade the intestinal mucosa or lymphoid tissue, such as Peyer's patches, initiating a granulomatous inflammatory response characteristic of the disease.
Clinical Presentation and Symptoms
Symptoms of abdominal tuberculosis are notoriously varied and depend heavily on the specific organs involved. Patients frequently report persistent abdominal pain, which may mimic other surgical conditions. Systemic signs such as low-grade fever, night sweats, significant weight loss, and profound fatigue are common. Gastrointestinal disturbances, including chronic diarrhea, constipation, or alternating bowel habits, are also highly prevalent, often leading to initial misdiagnosis as inflammatory bowel disease.
Common Manifestations by Organ System
Ileocecal involvement: The most frequent location, causing symptoms resembling Crohn’s disease.
Peritoneal infection: Leading to ascites and abdominal tenderness.
Gastrointestinal tract: Resulting in ulcers, strictures, or malabsorption.
Liver and spleen: Causing hepatosplenomegaly in disseminated cases.
Diagnostic Challenges
Diagnosing abdominal tuberculosis presents a significant clinical challenge due to its insidious onset and overlapping features with malignancies or other granulomatous diseases. Clinicians rely on a combination of clinical suspicion, imaging findings, and microbiological or histological confirmation. Traditional microbiological methods, such as culture, are often slow and have low sensitivity, while histopathology demonstrating granulomas with caseous necrosis remains a cornerstone, though definitive identification of the organism is ideal.
Treatment Protocols
The mainstay of treatment for abdominal tuberculosis is a prolonged course of multi-drug anti-tuberculous therapy, typically lasting six to nine months. The standard regimen includes an initial intensive phase with isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by a continuation phase with isoniazid and rifampicin. Adherence to this schedule is critical to prevent the development of drug-resistant strains and to ensure complete eradication of the infection.
